Use of 5'-methylthioadenosine (MTA) in the prevention and/or treatment of autoimmune diseases and/or transplant rejection

Details for Australian Patent Application No. 2005329287 (hide)

Owner Proyecto De Biomedicina Cima S.L.

Inventors Ruiz Garcia-Trevijano, Elena; Moreno Bruna, Beatriz; Corrales Izquierdo, Fernando; Villoslada Diaz, Pablo; Berasain Lasarte, Carmen; Avila Zaragoza, Matias

Agent Intellepro

Pub. Number AU-B-2005329287 (Modified Examination)

PCT Pub. Number WO2006/097547

Filing date 17 March 2005

Wipo publication date 21 September 2006

Acceptance publication date 27 January 2011

International Classifications

A61K 31/7076 (2006.01)

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

Event Publications

11 October 2007 PCT application entered the National Phase

  PCT publication WO2006/097547 Priority application(s): WO2006/097547

27 January 2011 Application Accepted

  Published as AU-B-2005329287 (Modified Examination)

26 May 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005329313-Methods and tool for maintenance of hard surfaces, and a method for manufacturing such a tool

2005329270-Improvements in or relating to cleaning compositions